1. Home
  2. AXTI vs ADAG Comparison

AXTI vs ADAG Comparison

Compare AXTI & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXTI
  • ADAG
  • Stock Information
  • Founded
  • AXTI 1986
  • ADAG 2011
  • Country
  • AXTI United States
  • ADAG China
  • Employees
  • AXTI N/A
  • ADAG N/A
  • Industry
  • AXTI Semiconductors
  • ADAG Biotechnology: Pharmaceutical Preparations
  • Sector
  • AXTI Technology
  • ADAG Health Care
  • Exchange
  • AXTI Nasdaq
  • ADAG Nasdaq
  • Market Cap
  • AXTI 94.4M
  • ADAG 110.8M
  • IPO Year
  • AXTI 1998
  • ADAG 2021
  • Fundamental
  • Price
  • AXTI $3.11
  • ADAG $2.20
  • Analyst Decision
  • AXTI Strong Buy
  • ADAG Strong Buy
  • Analyst Count
  • AXTI 4
  • ADAG 2
  • Target Price
  • AXTI $4.60
  • ADAG $7.00
  • AVG Volume (30 Days)
  • AXTI 659.6K
  • ADAG 109.6K
  • Earning Date
  • AXTI 10-30-2025
  • ADAG 08-12-2025
  • Dividend Yield
  • AXTI N/A
  • ADAG N/A
  • EPS Growth
  • AXTI N/A
  • ADAG N/A
  • EPS
  • AXTI N/A
  • ADAG N/A
  • Revenue
  • AXTI $86,080,000.00
  • ADAG $103,204.00
  • Revenue This Year
  • AXTI N/A
  • ADAG $9,789.15
  • Revenue Next Year
  • AXTI $31.28
  • ADAG $29.92
  • P/E Ratio
  • AXTI N/A
  • ADAG N/A
  • Revenue Growth
  • AXTI N/A
  • ADAG N/A
  • 52 Week Low
  • AXTI $1.13
  • ADAG $1.33
  • 52 Week High
  • AXTI $3.29
  • ADAG $3.58
  • Technical
  • Relative Strength Index (RSI)
  • AXTI 65.96
  • ADAG 53.56
  • Support Level
  • AXTI $2.91
  • ADAG $2.11
  • Resistance Level
  • AXTI $2.95
  • ADAG $2.24
  • Average True Range (ATR)
  • AXTI 0.22
  • ADAG 0.20
  • MACD
  • AXTI 0.05
  • ADAG -0.01
  • Stochastic Oscillator
  • AXTI 85.37
  • ADAG 53.33

About AXTI AXT Inc

AXT Inc is a developer and producer of compound and single element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.

Share on Social Networks: